CARDIFF ONCOLOGY, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38d90745-3f0f-446d-af51-c61926c39e84/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $593.0k | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-067464 |
| FY 2024 | $683.0k | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-028992 |
| FY 2023 | $488.0k | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-007948 |
| FY 2022 | $386.0k | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-006037 |
| FY 2021 | $359.0k | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003808 |
| FY 2020 | $366.0k | 2020-01-01 – 2020-12-31 | evidence 0001628280-22-003808 |
| FY 2019 | $244.6k | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002424 |
| FY 2018 | $378.3k | 2018-01-01 – 2018-12-31 | evidence 0001628280-20-002424 |
| FY 2017 | $505.4k | 2017-01-01 – 2017-12-31 | evidence 0001628280-18-002226 |
| FY 2016 | $381.1k | 2016-01-01 – 2016-12-31 | evidence 0001628280-17-002601 |
| FY 2015 | $312.8k | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-012562 |
| FY 2014 | $280.2k | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-019213 |
| FY 2013 | $2.8M | 1999-08-04 – 2014-03-31 | evidence 0001104659-14-037604 |
| FY 2012 | $2.6M | 1999-08-04 – 2013-03-31 | evidence 0001104659-13-041327 |
| FY 2011 | $2.0M | 1999-08-04 – 2012-03-31 | evidence 0001104659-12-037472 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CARDIFF ONCOLOGY, INC. — all facts · Net Income · Operating Income